Drug that targets an inflammatory enzyme could help prevent lung cancer

AI Summary

A drug targeting an inflammatory enzyme shows promise in preventing lung cancer, a disease causing over 100,000 deaths annually in the United States. While smoking is the main risk factor, other environmental exposures also contribute to disease incidence.

Every year, lung cancer kills more than 100,000 people in the United States. Smoking is the leading risk factor for lung cancer, but other environmental exposures can also contribute to the disease.